BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Cellomics Incorporated

Cellomics, Inc. is ushering in the post-genomic era in drug discovery -- the era of the cell. Cellomics believe that understanding how drugs affect cellular processes and cellular pathways in situ is the most biologically reliable route to discovering effective new medicines. Cellomics is the only company that provides complete systems for high content screening based on multiparametric image analyses of intact cells, and ultra high throughput screening systems for primary screening. By coupling the power of fluorescence imaging with advances in cell biology, bioinformatics and robotics, Cellomics empowers drug discovery groups with the ability to rapidly identify drug candidates and narrow their analysis to those that are most likely to succeed through clinical trials.


Contact Details:
635 William Pitt Way
Pittsburgh
PA
15238
United States of America
Tel:412 826 3600
Fax:412 826 3850
Email:
WWW:

www.cell.com/




Loading...

Recent Publications by Cellomics Incorporated:

Differential effect of ascorbic acid and n-acetyl-L-cysteine on arsenic trioxide-mediated oxidative stress in human leukemia (HL-60) cells.
Arsenic trioxide (ATO) has been recommended for the treatment of...
15th August, 2008
Cellomics and Toxicogenomics Research Laboratory, NIH-RCMI Center for J Biochem Mol Toxicol. 2008;22(2):85-92.
DOI Direct Link
Ultra-fast simultaneous detection of obesity-related coenzymes in mice using microchip electrophoresis with a LIF detector.
Hepatic acyl-coenzyme A synthetase (ACS), carnitine palmitoyltransferase-I...
19th July, 2008
Cellomics Research Center, Korea Research Institute of Bioscience and Anal Chim Acta. 2008 Jun 30;619(1):94-100. Epub 2008 Jan 15.
DOI Direct Link
Modulation of telomerase activity and human telomerase reverse transcriptase expression by caspases and bcl-2 family proteins in Cisplatin-induced cell death.
BACKGROUND: Human telomerase is a ribonucleoprotein polymerase, which...
25th December, 2007
Cellomics Research Center, Korea Research Institute of Bioscience and Korean J Lab Med. 2006 Aug;26(4):287-93.
Up-regulation of Mac-2 binding protein by hTERT in gastric cancer.
Mac-2 binding protein (Mac-2BP) is a secreted tumor antigen that is...
15th May, 2007
Cellomics Research Center, KRIBB, Daejeon, Korea. Int J Cancer. 2007 Feb 15;120(4):813-20.
DOI Direct Link
Microarray analysis of mercury-induced changes in gene expression in human liver carcinoma (HepG2) cells: importance in immune responses.
Mercury is widely distributed in the biosphere, and its toxic effects have...
8th February, 2007
Cellomics and Toxicogenomics Research Laboratory, NIH-RCMI Center for Int J Environ Res Public Health. 2006 Jun;3(2):141-73.

View more Cellomics Incorporated research publications.

BioNews Results for Cellomics Incorporated:

Thermo Fisher Scientific Announces Dates for Annual User Groups and Road Shows for High Content Analysis
BioPortfolio:  Aug 26 2008 4:01PM Matching: cellomics
ArunA Biomedical names William T Sharp as president, CEO
PharmaBiz:  Aug 2 2008 11:05AM Matching: cellomics

Cellomics Incorporated Patents:

US Patent No.Title
7410769 Peptide biosensors for anthrax protease
6759206 System for cell-based screening
6756207 System for cell-based screening
6727071 System for cell-based screening
6716588 System for cell-based screening

View more Cellomics Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 200 times since April 2007, the link to the organisation's website has been followed 36 times

Recent Search Terms used to find this page: assaybuilder | Cellomics Incorporated | ASSAYbuilder Thermo Fisher | .

Search for more companies in Pittsburgh

Search for more companies in PA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cellomics Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.